Vincerx Pharma, Inc.
Vincerx Pharma, Inc. (VINC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · VINC · as of Dec 31, 2024
Ownership Breakdown
20
Institutional Holders
▼ 6 vs Q3
$1.26M
Total Inst. Value
▼ $6.63M vs Q3
5.23M
Shares Outstanding
freeFloat 90.68%
4.80M
13F Shares Held
▼ 6.22M vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
VINC largest shareholders · institutional ownership
Q4 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
STATE STREET CORP pharmaceutical preparations | 57.0K | 12.48% | 12.48% | $14.98M | Feb 14, 2025 | — held |
COLONY GROUP, LLC pharmaceutical preparations | 10.9K | 2.39% | 2.39% | $2.87M | May 29, 2025 | ▲ 10.9K |
SAGE RHINO CAPITAL LLC pharmaceutical preparations | 1.70M | 0.93% | 0.93% | $447.66M | Feb 6, 2025 | — held |
ROCK SPRINGS CAPITAL MANAGEMENT LP pharmaceutical preparations | 891.7K | 0.49% | 0.49% | $234.34M | Feb 14, 2025 | — held |
MORGAN STANLEY pharmaceutical preparations | 2.1K | 0.46% | 0.46% | $549,000 | May 15, 2025 | ▲ 340 |
GOLDMAN SACHS GROUP INC pharmaceutical preparations | 631.4K | 0.35% | 0.35% | $165.93M | Feb 11, 2025 | ▼ 27 |
ARMISTICE CAPITAL, LLC pharmaceutical preparations | 567.0K | 0.31% | 0.31% | $149.01M | Feb 14, 2025 | ▼ 2.14M |
VANGUARD GROUP INC pharmaceutical preparations | 286.4K | 0.16% | 0.16% | $75.31M | Feb 11, 2025 | ▼ 341.1K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 241.5K | 0.13% | 0.13% | $63.49M | Feb 12, 2025 | ▼ 9.3K |
RUBRIC CAPITAL MANAGEMENT LP pharmaceutical preparations | 116.9K | 0.06% | 0.06% | $30.71M | Feb 14, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2024 vs prior quarter
Q4 2024
5
Increased
+148.9K shares0
New Positions
first time holders8
Decreased
−2.55M shares7
Sold Out
fully exitedNet shares change (top 50)
2.40M
+148.9K / −2.55M
Net new holders
-10
0 new / 7 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
VINC insider trading · insider activity
Source: SEC Form 4
24
Buy transactions
22
Sell transactions
1.09
Buy/Sell ratio
$2M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
THOMAS TOM C See Remarks | Aug 12, 2024 | Award | 175,000 | $0.55 | $96.3K | 175.0K | Form 4 ↗ |
THOMAS TOM C See Remarks | Aug 12, 2024 | Award | 31,250 | $0.55 | $17.2K | 125.0K | Form 4 ↗ |
THOMAS TOM C See Remarks | Aug 12, 2024 | Award | 93,750 | $0.55 | $51.6K | 93.8K | Form 4 ↗ |
THOMAS TOM C See Remarks | Aug 12, 2024 | Award | 86,000 | $0.55 | $47.3K | 86.0K | Form 4 ↗ |
THOMAS TOM C See Remarks | Aug 12, 2024 | Award | 58,000 | $0.55 | $31.9K | 58.0K | Form 4 ↗ |
THOMAS TOM C See Remarks | Aug 12, 2024 | Award | 56,000 | $0.55 | $30.8K | 56.0K | Form 4 ↗ |
THOMAS TOM C See Remarks | Aug 12, 2024 | Award | 55,250 | $0.55 | $30.4K | 55.3K | Form 4 ↗ |
THOMAS TOM C See Remarks | Aug 12, 2024 | D-Return | 86,000 | $1.17 | $100.6K | 0 | Form 4 ↗ |
THOMAS TOM C See Remarks | Aug 12, 2024 | D-Return | 56,000 | $0.82 | $45.9K | 0 | Form 4 ↗ |
THOMAS TOM C See Remarks | Aug 12, 2024 | D-Return | 31,250 | $7.38 | $230.6K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Vincerx Pharma, Inc. (VINC) is primarily owned by institutional investors, who hold approximately 91.7% of total shares outstanding. Company insiders own approximately 9.32%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Vincerx Pharma, Inc. is STATE STREET CORP, holding approximately 57,016 shares — equal to 12.48% of outstanding shares — as of December 31, 2024.
A total of 20 institutional investors currently hold VINC stock, with a combined institutional value of approximately $1,260,341 as of the most recent 13F filing period.
Frequently asked questions
VINC ownershipVincerx Pharma, Inc. (VINC) is primarily owned by institutional investors, who hold approximately 91.7% of shares. The largest shareholder is STATE STREET CORP with a 12.48% stake. Company insiders hold 9.32%. Data sourced from SEC Form 13F as of December 31, 2024.